3341 |
7A25 |
D_A |
Sb23 synthetic-Nanobody |
SARS-CoV-2 Spike glycoprotein |
Severe acute respiratory syndrome coronavirus 2, synthetic construct |
EM |
3.06 | 10.1038/s41467-020-19204-y |
3342 |
7A25 |
F_C |
Sb23 synthetic-Nanobody |
SARS-CoV-2 Spike glycoprotein |
Severe acute respiratory syndrome coronavirus 2, synthetic construct |
EM |
3.06 | 10.1038/s41467-020-19204-y |
3343 |
7A25 |
E_B |
Sb23 synthetic-Nanobody |
SARS-CoV-2 Spike glycoprotein |
Severe acute respiratory syndrome coronavirus 2, synthetic construct |
EM |
3.06 | 10.1038/s41467-020-19204-y |
3344 |
7A29 |
D_A |
Sb23 synthetic-Nanobody |
SARS-CoV-2 Spike glycoprotein |
Severe acute respiratory syndrome coronavirus 2, synthetic construct |
EM |
2.94 | 10.1038/s41467-020-19204-y |
3345 |
7A29 |
F_C |
Sb23 synthetic-Nanobody |
SARS-CoV-2 Spike glycoprotein |
Severe acute respiratory syndrome coronavirus 2, synthetic construct |
EM |
2.94 | 10.1038/s41467-020-19204-y |
3346 |
7A29 |
E_B |
Sb23 synthetic-Nanobody |
SARS-CoV-2 Spike glycoprotein |
Severe acute respiratory syndrome coronavirus 2, synthetic construct |
EM |
2.94 | 10.1038/s41467-020-19204-y |
3347 |
7A3N |
HL_A |
EDE1 C10 Fab |
Zika virus envelope glycoprotein E |
Zika virus, Homo sapiens |
XRD |
2.1 | 10.1016/j.cell.2021.11.010 |
3348 |
7A3T |
HL_A |
EDE1 C8 Fab |
Dengue virus type 3 envelope glycoprotein E |
dengue virus type 3, Homo sapiens |
XRD |
2.65 | 10.1016/j.cell.2021.11.010 |
3349 |
7A3U |
HL_A |
EDE1 C10 Fab |
Zika virus envelope glycoprotein E |
Zika virus, Homo sapiens |
XRD |
3 | 10.1016/j.cell.2021.11.010 |
3350 |
7A5R |
HL_A |
CR3022 Fab |
SARS-CoV-2 Spike glycoprotein |
Homo sapiens, Severe acute respiratory syndrome coronavirus 2 |
EM |
3.7 | 10.1038/s41467-020-19146-5 |
3351 |
7A5R |
IM_B |
CR3022 Fab |
SARS-CoV-2 Spike glycoprotein |
Homo sapiens, Severe acute respiratory syndrome coronavirus 2 |
EM |
3.7 | 10.1038/s41467-020-19146-5 |
3352 |
7A5S |
HL_A |
CR3022 Fab |
SARS-CoV-2 Spike glycoprotein |
Homo sapiens, Severe acute respiratory syndrome coronavirus 2 |
EM |
3.9 | 10.1038/s41467-020-19146-5 |
3353 |
7A5S |
IM_B |
CR3022 Fab |
SARS-CoV-2 Spike glycoprotein |
Homo sapiens, Severe acute respiratory syndrome coronavirus 2 |
EM |
3.9 | 10.1038/s41467-020-19146-5 |
3354 |
7A65 |
CB_A |
MRK16 Fab |
Multidrug resistance protein 1 |
Homo sapiens, Mus musculus |
EM |
3.9 | 10.1073/pnas.2010264117 |
3355 |
7A69 |
CB_A |
MRK16 Fab |
Multidrug resistance protein 1 |
Homo sapiens, Mus musculus |
EM |
3.2 | 10.1073/pnas.2010264117 |
3356 |
7A6C |
CB_A |
MRK16 Fab |
Multidrug resistance protein 1 |
Homo sapiens, Mus musculus |
EM |
3.6 | 10.1073/pnas.2010264117 |
3357 |
7A6E |
CB_A |
MRK16 Fab |
Multidrug resistance protein 1 |
Homo sapiens, Mus musculus |
EM |
3.6 | 10.1073/pnas.2010264117 |
3358 |
7A6F |
CB_A |
MRK16 Fab |
Multidrug resistance protein 1 |
Homo sapiens, Mus musculus |
EM |
3.5 | 10.1073/pnas.2010264117 |
3359 |
7A6O |
B_A |
VHH81 Nanobody |
Recombinant von Willebrand factor AIM-A1 domain |
Homo sapiens, Lama glama |
XRD |
2.12 | 10.1038/s41467-021-22634-x |
3360 |
7AHV |
AB_H |
Mim8 Fab |
Coagulation factor IX |
Homo sapiens |
XRD |
3.11 | 10.1182/blood.2020010331 |